" /> Buschke-ollendorff syndrome - CISMeF





Preferred Label : Buschke-ollendorff syndrome;

Symbol : BOS;

CISMeF acronym : BOS;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : Dermatofibrosis, disseminated, with osteopoikilosis; Dermatofibrosis lenticularis disseminata with osteopoikilosis; Osteopathia condensans disseminata; DERMATOOSTEOPOIKILOSIS;

Included titles and symbols : Osteopoikilosis, isolated; Dermatofibrosis lenticularis disseminata, isolated; Osteopoikilosis with melorheostosis;

Description : Buschke-Ollendorff syndrome is an autosomal dominant connective tissue disorder manifest by multiple subcutaneous nevi or nodules. They may be either elastin-rich (elastoma) or collagen-rich (dermatofibrosis lenticularis disseminata) on histologic examination. The lesions are usually nontender and firm. Affected individuals also have osteopoikilosis (OPK), literally meaning 'spotted bones,' which are osteosclerotic foci that occur in the epiphyses and metaphyses of long bones, wrist, foot, ankle, pelvis, and scapula. Some individuals have both skin and bone manifestations, whereas others may lack skin or bone manifestations. Some individuals may also have melorheostosis (155950), which is characterized by 'flowing' hyperostosis of the cortex of tubular bones. Most reported cases of BOS and OPK are benign, and the bone lesions are found incidentally, although some patients may have joint pain (reviews by Hellemans et al., 2004 and Zhang et al., 2009).;

Inheritance : Autosomal dominant;

Molecular basis : Caused by mutation in the LEM domain-containing-3 gene (LEMD3, 607844.0001);

Prefixed ID : #166700;

Details


You can consult :


Nous contacter.
18/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.